Related Experiment Video
Updated: Nov 17, 2025

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
AI-Driver: an ensemble method for identifying driver mutations in personal cancer genomes
Haoxuan Wang1, Tao Wang2, Xiaolu Zhao3
1Center of Basic Medical Research, Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing 100191, China.
AI-Driver is a new tool that predicts cancer driver mutations from somatic missense mutations. It outperforms existing methods and aids in precision cancer medicine by identifying critical mutations for targeted therapies.
Area of Science:
- Genomics
- Computational Biology
- Cancer Research
Background:
- Distinguishing cancer driver mutations from passenger mutations is crucial for precision medicine.
- Existing methods for driver prediction lack the necessary resolution for exome sequencing data.
Purpose of the Study:
- To develop an advanced computational method for predicting the driver status of somatic missense mutations.
- To improve the accuracy and reliability of driver mutation identification in cancer research.
Main Methods:
- Developed an ensemble method named AI-Driver, utilizing 23 pathogenicity features.
- Trained and validated the AI-Driver model on extensive datasets, comparing its performance against individual tools and existing cancer-specific methods.
- Generated pre-computed AI-Driver scores for all human missense variants.
Main Results:
- AI-Driver demonstrated superior and stable performance across four independent benchmarks.
- The tool outperformed individual prediction tools and two existing cancer-specific driver prediction methods.
- Pre-computed scores are available for all human missense variants.
Conclusions:
- AI-Driver offers a significant advancement in identifying driver mutations from large-scale sequencing studies.
- The tool and its associated database are valuable resources for personal cancer genome analysis, drug target discovery, and biomarker development.
- AI-Driver supports precision cancer medicine by enabling more accurate identification of mutations driving tumor growth.
More Related Videos
Related Concept Videos
Cancer
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer Survival Analysis
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

